E2F1 and B-cell non-Hodgkin lymphoma: Previous studies have also pointed out a tumor suppressor role for mir-29b in HM specifically DLBCL, mantle cell lymphoma, and B-cell lymphomas in general by targeting the oncogenic transcription factor E2F1 [36].